Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2023 09:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Participate in Goldman Sachs 44th Annual Global Healthcare Conference

ZUG, Switzerland and CAMBRIDGE, Mass., June 13, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
May 08, 2023 16:01 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

-Regulatory submissions complete for exagamglogene autotemcel (exa-cel), formerly known as CTX001™, in the U.S. for transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease (SCD)- ...
May 02, 2023 08:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Participate Upcoming Investor Conferences

ZUG, Switzerland and CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
April 13, 2023 16:01 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Participate in Needham’s 22nd Annual Healthcare Conference

ZUG, Switzerland and CAMBRIDGE, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
March 29, 2023 08:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Announces Departure of Board Member

ZUG, Switzerland and BOSTON, March 29, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious...
March 14, 2023 18:02 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting

ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious...
March 13, 2023 16:15 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Announces Transition of Chief Financial Officer

ZUG, Switzerland and BOSTON, March 13, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious...
February 27, 2023 08:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference

ZUG, Switzerland and BOSTON, Feb. 27, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious...
February 21, 2023 16:01 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

-Regulatory submissions complete for exagamglogene autotemcel (exa-cel) in Europe for transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD); U.S. rolling Biologics Licensing...
February 08, 2023 08:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...